| scholarly article | Q13442814 |
| P2093 | author name string | Jeremy J Mao | |
| Eduardo K Moioli | |||
| Liu Hong | |||
| Paul A Clark | |||
| Jesse Guardado | |||
| P2860 | cites work | Mesenchymal stem cells used for rabbit tendon repair can form ectopic bone and express alkaline phosphatase activity in constructs. | Q51633203 |
| Adult stem cell driven genesis of human-shaped articular condyle. | Q51634553 | ||
| Tissue-engineered neogenesis of human-shaped mandibular condyle from rat mesenchymal stem cells. | Q51794913 | ||
| Effect of c-Sterilization Process on PLGA Microspheres Loaded with Insulin-Like Growth Factor - I (IGF-I) | Q51796950 | ||
| The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres | Q51805645 | ||
| Rescue of coronal suture fusion using transforming growth factor-beta 3 (Tgf-beta 3) in rabbits with delayed-onset craniosynostosis. | Q52100348 | ||
| TGF-beta 3 expression during umbilical cord development and its alteration in pre-eclampsia. | Q52120942 | ||
| Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency. | Q52143092 | ||
| Tooth induction and temporal patterning in palatal epithelium of fetal mice. | Q52261887 | ||
| Transforming growth factor-beta 3(Tgf-beta3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo. | Q53874055 | ||
| Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres | Q70216445 | ||
| In vitro release kinetics of biologically active transforming growth factor-beta 1 from a novel porous glass carrier | Q73418940 | ||
| Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles | Q73430220 | ||
| Indirect mitogenic effect of transforming growth factor-beta on cell proliferation of subconjunctival fibroblasts | Q74312994 | ||
| TGF-beta s stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts | Q74446996 | ||
| Stimulation of bone healing by transforming growth factor-beta 1 released from polymeric or ceramic implants | Q77127032 | ||
| Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering | Q77460826 | ||
| TGF-beta3 in the treatment of pressure ulcers: a preliminary report | Q77783101 | ||
| Release of bioactive transforming growth factor beta(3) from microtextured polymer surfaces in vitro and in vivo | Q78593623 | ||
| Scar-free healing: from embryonic mechanisms to adult therapeutic intervention | Q24675326 | ||
| Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration | Q28578731 | ||
| TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. | Q30470194 | ||
| Determination of water-soluble acid distribution in poly(lactide-co-glycolide). | Q30887055 | ||
| A method to protect sensitive molecules from a light-induced polymerizing environment. | Q31143015 | ||
| Craniofacial disorders caused by mutations in homeobox genes MSX1 and MSX2. | Q33957945 | ||
| Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation | Q34527773 | ||
| Mechanobiology of craniofacial sutures | Q35009879 | ||
| Advances in drug delivery for articular cartilage | Q35029750 | ||
| Growth and development: hereditary and mechanical modulations | Q35793143 | ||
| TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing | Q35841836 | ||
| Mesenchymal stem cells: isolation and therapeutics | Q35877577 | ||
| Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens | Q35961159 | ||
| Chitosan-based particles as controlled drug delivery systems | Q36084966 | ||
| Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro | Q38550543 | ||
| In vitro effects of brain derived neurotrophic factor released from microspheres | Q38573617 | ||
| Prolonged cytotoxic effect of colchicine released from biodegradable microspheres | Q40512196 | ||
| In vitro study of GDNF release from biodegradable PLGA microspheres. | Q40578254 | ||
| The effect of TGF-beta delivered through a collagen scaffold on wound healing | Q40813678 | ||
| Basic fibroblast growth factor adsorption and release properties of calcium phosphate | Q40851732 | ||
| Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. | Q42098930 | ||
| TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. | Q43583645 | ||
| Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis | Q43628533 | ||
| Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts | Q43701879 | ||
| Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates | Q44023947 | ||
| TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses | Q44156072 | ||
| TGF-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesion | Q44176635 | ||
| Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process | Q44240137 | ||
| Biological activity of rhBMP-2 released from PLGA microspheres | Q44243333 | ||
| Tissue-engineered trachea from sheep marrow stromal cells with transforming growth factor beta2 released from biodegradable microspheres in a nude rat recipient | Q44956836 | ||
| Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration. | Q45040606 | ||
| Exogenous transforming growth factor-beta 2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent. | Q45938320 | ||
| Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix | Q46046620 | ||
| Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. | Q46443372 | ||
| Transforming growth factor-beta isoform expression in the perisutural tissues of craniosynostotic rabbits. | Q47275668 | ||
| TGF-beta 3 decreases type I collagen and scarring after labioplasty | Q47810539 | ||
| Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration. | Q48149688 | ||
| Tissue-engineered rabbit cranial suture from autologous fibroblasts and BMP2. | Q51612479 | ||
| P433 | issue | 3 | |
| P921 | main subject | microsphere | Q1759020 |
| P304 | page(s) | 537-546 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Tissue Engineering | Q15752874 |
| P1476 | title | Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells | |
| P478 | volume | 12 |
| Q46915561 | A shorter telomere is the key factor in preventing cultured human mesenchymal stem cells from senescence escape |
| Q98726592 | Approaches to promoting bone marrow mesenchymal stem cell osteogenesis on orthopedic implant surface |
| Q39971796 | Autologous stem cell regeneration in craniosynostosis |
| Q36502929 | Biomimetic materials for tissue engineering |
| Q34090214 | CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model |
| Q36219521 | Cell- and gene-based therapeutic strategies for periodontal regenerative medicine |
| Q36633835 | Craniofacial tissue engineering by stem cells |
| Q43617316 | Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ϵ-caprolactone nanoparticles for protein/peptide drug delivery |
| Q30429889 | Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres |
| Q92599918 | Effect of dose and release rate of CTGF and TGFβ3 on avascular meniscus healing |
| Q51767489 | Effects of releasing recombinant human growth and differentiation factor-5 from poly(lactic-co-glycolic acid) microspheres for repair of the rat degenerated intervertebral disc. |
| Q37584467 | Generation of osteochondral tissue constructs with chondrogenically and osteogenically predifferentiated mesenchymal stem cells encapsulated in bilayered hydrogels. |
| Q37261117 | Heat and radiofrequency plasma glow discharge pretreatment of a titanium alloy: evidence [corrected] for enhanced osteoinductive properties. |
| Q37714452 | Human mesenchymal stem cells and their use in cell-based therapies. |
| Q35875482 | IGF1 Promotes Adipogenesis by a Lineage Bias of Endogenous Adipose Stem/Progenitor Cells |
| Q43241239 | IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1β-mediated degradation of nucleus pulposus in vitro |
| Q37521185 | Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model |
| Q90884607 | Impact of UV sterilization and short term storage on the in vitro release kinetics and bioactivity of biomolecules from electrospun scaffolds |
| Q34349134 | Incorporation of proteinase inhibitors into silk-based delivery devices for enhanced control of degradation and drug release |
| Q39971776 | Inhibition of osteogenic differentiation of human mesenchymal stem cells |
| Q39978227 | Labeling of mesenchymal stem cells by bioconjugated quantum dots |
| Q33668926 | Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering |
| Q97519667 | Mechanically-Activated Microcapsules for 'On-Demand' Drug Delivery in Dynamically Loaded Musculoskeletal Tissues |
| Q50210424 | Mechano-growth factor enhances differentiation of bone marrow-derived mesenchymal stem cells. |
| Q37196614 | Mesenchymal stem cells in tissue repairing and regeneration: Progress and future |
| Q30459545 | Osteochondral interface regeneration of the rabbit knee with macroscopic gradients of bioactive signals |
| Q37352861 | PEG hydrogels for the controlled release of biomolecules in regenerative medicine |
| Q47380821 | PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics |
| Q41822690 | Postnatal epithelium and mesenchyme stem/progenitor cells in bioengineered amelogenesis and dentinogenesis |
| Q90218504 | Progress in Research on the Role of FGF in the Formation and Treatment of Corneal Neovascularization |
| Q46947174 | Reducing scar formation by regulation of IL-1 and MMP-9 expression by using sustained release of prednisolone-loaded PDLL microspheres in a murine wound model. |
| Q33652109 | Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study |
| Q40354562 | Slow chlorine releasing compounds: A viable sterilisation method for bioabsorbable nanocomposite biomaterials |
| Q34343825 | Stem Cells and Regenerative Medicine: Accomplishments to Date and Future Promise |
| Q34598531 | Sustained levels of FGF2 maintain undifferentiated stem cell cultures with biweekly feeding |
| Q37707669 | Synergistic effects of overexpression of BMP‑2 and TGF‑β3 on osteogenic differentiation of bone marrow mesenchymal stem cells |
| Q50441810 | TGF‐β3 immobilized PLGA‐gelatin/chondroitin sulfate/hyaluronic acid hybrid scaffold for cartilage regeneration |
| Q38845875 | Three-dimensional printed multiphase scaffolds for regeneration of periodontium complex |
| Q37471472 | Transient exposure to transforming growth factor beta 3 improves the mechanical properties of mesenchymal stem cell-laden cartilage constructs in a density-dependent manner. |
| Q33668984 | Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits. |
Search more.